SCTX LLY scribe Therapeutics - IPO price expected between $13 and $15 per share - SEC filing Scribe Therapeutics - launches IPO of 7,150,000
SCTX LLY scribe Therapeutics - IPO price expected between $13 and $15 per share - SEC filing Scribe Therapeutics - launches IPO of 7,150,000 common shares - SEC filing - Aventis and genzyme to purchase $7.50M in shares via concurrent private placement - SEC filing Scribe Therapeutics Inc - Eli Lilly has indicated inter